ocr: 100r Better Worse - - 80 Improvement - - - - 60 7-Unit 4-Unit / Hf - - - - - - - à X - 4 - 40 20 Placebo Cognex 160 mg - - - 15 10 5 0 5 10 15 20 25 30 Change in ADAS Cog Score from Baseline FIGURE 2. Cumulative Percent of Patients Completing 30 Weeks of Treatment Who Attained a Change in ADAS Cog Score From Baseline at Least as Large as the Value on the X Axis. The display is based on scores obtained from a subset of patients (ie, 64% of the 184 randomized to placebo and 27% of the 239r randomized t0 the 160 mg/day treament groupi.
